Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 6/10/13 → 2/27/25 |
Funding
- Eisai Incorporated: $859,461.00
A Placebo-controlled, Double-blind, Parallel-group, Bayesian Adaptive Randomization Design and Dose Regimen-finding Study to Evaluate Safety, Tolerability and Efficacy of BAN2401 in Subjects With Early Alzheimer#s Disease
- Jicha, Gregory (PI)
- Caban-Holt, Allison (Former CoI)
- Smith, Charles (Former CoI)